Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 84 73096 64989 399122 391--
Entreprise Value (EV)1 151 578159 446146 192170 659164 472160 370
P/E ratio -115x14,6x12,5x14,9x13,5x12,4x
Yield 3,05%2,69%2,93%2,15%2,19%2,25%
Capitalization / Revenue 0,44x0,38x0,33x0,42x0,41x0,39x
EV / Revenue 0,78x0,62x0,54x0,59x0,55x0,51x
EV / EBITDA 11,9x9,23x8,07x9,02x8,43x7,99x
Price to Book 1,17x1,51x1,29x1,63x1,52x1,44x
Nbr of stocks (in thousands) 1 293 1991 300 9641 308 9131 321 000--
Reference price (USD) 65,574,368,392,792,792,7
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 194 579256 776268 706288 926300 547313 791
EBITDA1 12 73417 27418 10818 91019 51020 082
Operating profit (EBIT)1 10 25515 33916 00816 53816 94717 714
Operating Margin 5,27%5,97%5,96%5,72%5,64%5,65%
Pre-Tax Profit (EBT)1 1 4068 9979 77011 18012 46613 058
Net income1 -5946 6347 1798 0709 0479 652
Net margin -0,31%2,58%2,67%2,79%3,01%3,08%
EPS2 -0,575,085,466,236,877,50
Dividend per Share2 2,002,002,001,992,032,09
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 69 09772 61673 79473 70973 06275 045
EBITDA1 4 7445 4314 6463 9234 8494 941
Operating profit (EBIT)1 4 2054 8874 0733 3734 2154 379
Operating Margin 6,09%6,73%5,52%4,58%5,77%5,84%
Pre-Tax Profit (EBT)1 2 9703 7352 1451 9653 0093 495
Net income1 2 2232 7831 5981 3902 2682 433
Net margin 3,22%3,83%2,17%1,89%3,10%3,24%
EPS2 1,682,101,201,131,741,79
Dividend per Share ------
Announcement Date 05/04/202108/04/202111/03/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 66 84862 79756 79348 26842 08137 980
Net Cash position1 ------
Leverage (Debt / EBITDA) 5,25x3,64x3,14x2,55x2,16x1,89x
Free Cash Flow1 6 82810 39113 42810 50810 41011 262
ROE (Net Profit / Equities) 15,4%15,1%14,8%14,4%13,2%13,7%
Shareholders' equity1 -3 84643 80948 51055 85568 30870 399
ROA (Net Profit / Asset) 5,08%4,41%4,35%4,11%4,09%4,27%
Assets1 -11 693150 315164 974196 228221 380226 137
Book Value Per Share2 55,849,153,056,961,064,6
Cash Flow per Share2 8,499,8512,19,6810,010,9
Capex1 2 0372 4572 4372 7692 8092 864
Capex / Sales 1,05%0,96%0,91%0,96%0,93%0,91%
Announcement Date 02/20/201902/12/202002/16/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 122 390 650 000
Net sales (USD) 268 706 000 000
Number of employees 256 500
Sales / Employee (USD) 1 047 587
Free-Float 75,7%
Free-Float capitalization (USD) 92 593 454 292
Avg. Exchange 20 sessions (USD) 498 202 653
Average Daily Capital Traded 0,41%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA